Business Wire
BusinessAndy Jassy says AI inference still far too costly for broad business use, points to Amazon’s chipsThe Apex TimesBusinessStarbucks set for next earnings, with analysts looking for double-digit EPS growthThe Apex TimesBusinessModerna and Merck diverge after early cancer-vaccine data in market testThe Apex TimesBusinessAlphabet highlights builders’ 3D and coding projects built with Gemini 4 ArgonThe Apex TimesBusinessLockheed Martin pairs an earnings beat with a higher 2026 outlook and a refreshed F-35 frameworkThe Apex TimesBusinessEli Lilly breaks ground on a Richmond-area manufacturing hub as it expands antibody-drug conjugate capacityThe Apex TimesBusinessAs Meta’s “Muse” AI gains users, costs may rise with it, according to a new reportThe Apex TimesBusinessMarket column points to Meta as top put-selling candidate among Tesla, Meta and BroadcomThe Apex TimesBusinessNike’s Valuation Comes Under Scrutiny as Investors Compare the Stock With Consumer Retail RivalsThe Apex TimesBusinessUnitedHealth jumps 11% in a week after third-quarter beat and raised 2026 outlookThe Apex TimesBusinessBlackRock is reported to be joining a push for “protected” bitcoin exposure productsThe Apex TimesBusinessApple’s iPhone Duo launches at $2,000-plus, but limited supply tests demandThe Apex TimesBusinessAndy Jassy says AI inference still far too costly for broad business use, points to Amazon’s chipsThe Apex TimesBusinessStarbucks set for next earnings, with analysts looking for double-digit EPS growthThe Apex TimesBusinessModerna and Merck diverge after early cancer-vaccine data in market testThe Apex TimesBusinessAlphabet highlights builders’ 3D and coding projects built with Gemini 4 ArgonThe Apex TimesBusinessLockheed Martin pairs an earnings beat with a higher 2026 outlook and a refreshed F-35 frameworkThe Apex TimesBusinessEli Lilly breaks ground on a Richmond-area manufacturing hub as it expands antibody-drug conjugate capacityThe Apex TimesBusinessAs Meta’s “Muse” AI gains users, costs may rise with it, according to a new reportThe Apex TimesBusinessMarket column points to Meta as top put-selling candidate among Tesla, Meta and BroadcomThe Apex TimesBusinessNike’s Valuation Comes Under Scrutiny as Investors Compare the Stock With Consumer Retail RivalsThe Apex TimesBusinessUnitedHealth jumps 11% in a week after third-quarter beat and raised 2026 outlookThe Apex TimesBusinessBlackRock is reported to be joining a push for “protected” bitcoin exposure productsThe Apex TimesBusinessApple’s iPhone Duo launches at $2,000-plus, but limited supply tests demandThe Apex TimesBusinessAndy Jassy says AI inference still far too costly for broad business use, points to Amazon’s chipsThe Apex TimesBusinessStarbucks set for next earnings, with analysts looking for double-digit EPS growthThe Apex TimesBusinessModerna and Merck diverge after early cancer-vaccine data in market testThe Apex TimesBusinessAlphabet highlights builders’ 3D and coding projects built with Gemini 4 ArgonThe Apex TimesBusinessLockheed Martin pairs an earnings beat with a higher 2026 outlook and a refreshed F-35 frameworkThe Apex TimesBusinessEli Lilly breaks ground on a Richmond-area manufacturing hub as it expands antibody-drug conjugate capacityThe Apex TimesBusinessAs Meta’s “Muse” AI gains users, costs may rise with it, according to a new reportThe Apex TimesBusinessMarket column points to Meta as top put-selling candidate among Tesla, Meta and BroadcomThe Apex TimesBusinessNike’s Valuation Comes Under Scrutiny as Investors Compare the Stock With Consumer Retail RivalsThe Apex TimesBusinessUnitedHealth jumps 11% in a week after third-quarter beat and raised 2026 outlookThe Apex TimesBusinessBlackRock is reported to be joining a push for “protected” bitcoin exposure productsThe Apex TimesBusinessApple’s iPhone Duo launches at $2,000-plus, but limited supply tests demandThe Apex TimesBusinessAndy Jassy says AI inference still far too costly for broad business use, points to Amazon’s chipsThe Apex TimesBusinessStarbucks set for next earnings, with analysts looking for double-digit EPS growthThe Apex TimesBusinessModerna and Merck diverge after early cancer-vaccine data in market testThe Apex TimesBusinessAlphabet highlights builders’ 3D and coding projects built with Gemini 4 ArgonThe Apex TimesBusinessLockheed Martin pairs an earnings beat with a higher 2026 outlook and a refreshed F-35 frameworkThe Apex TimesBusinessEli Lilly breaks ground on a Richmond-area manufacturing hub as it expands antibody-drug conjugate capacityThe Apex TimesBusinessAs Meta’s “Muse” AI gains users, costs may rise with it, according to a new reportThe Apex TimesBusinessMarket column points to Meta as top put-selling candidate among Tesla, Meta and BroadcomThe Apex TimesBusinessNike’s Valuation Comes Under Scrutiny as Investors Compare the Stock With Consumer Retail RivalsThe Apex TimesBusinessUnitedHealth jumps 11% in a week after third-quarter beat and raised 2026 outlookThe Apex TimesBusinessBlackRock is reported to be joining a push for “protected” bitcoin exposure productsThe Apex TimesBusinessApple’s iPhone Duo launches at $2,000-plus, but limited supply tests demandThe Apex Times
Back to front
UBS Flags Lockheed Martin Growth Not “Priced In,” Lifts Target as Defense Momentum Seen Across Segments
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 23, 1:49 PM EDT

UBS Flags Lockheed Martin Growth Not “Priced In,” Lifts Target as Defense Momentum Seen Across Segments

Analysts at UBS said Lockheed Martin’s upside could be larger than what the current stock price reflects, pointing to improving confidence in accelerating momentum across multiple business areas. Citi also raised its price target while keeping a Buy rating.

Lockheed Martin shares drew analyst attention on October 23 after UBS argued that the company’s growth potential is not fully reflected in the market, according to a report carried by Yahoo Finance.

The report said UBS characterized Lockheed Martin’s outlook as having room for upside because the current valuation does not appear to “price in” the pace of improvement the analyst expects. The message was framed as a momentum story, with confidence building that advances across Lockheed’s segments could accelerate rather than plateau.

In parallel, Citi reportedly raised its price target on Lockheed Martin to $706 from $691 while maintaining a Buy rating. The update, as described in the report, also pointed to increased confidence in accelerating momentum across Lockheed’s business segments.

Lockheed Martin, one of the largest defense contractors in the United States, runs its operations through multiple lines tied to defense spending cycles, program wins and execution, and production ramp-ups and sustainment work. In that context, analysts often focus on whether backlog is converting smoothly into deliveries and earnings, and whether newer programs and modernization efforts are gaining traction.

While the October 23 report emphasized the idea that upside remains, it did not lay out new program award announcements or specific quarterly drivers in the way an investor presentation or earnings release would. Instead, the thrust was valuation versus expectations, with the analyst framing the stock’s implied growth rate as potentially conservative.

For investors and defense market watchers, these kinds of notes tend to matter less for the immediate near-term mechanics and more for what they announcement about longer-run assumptions. If multiple sell-side firms begin to describe momentum as accelerating, it can indicate that expectations for execution, demand, or program performance are moving in a more favorable direction.

At the same time, the information available in the report falls short of the detail typically needed to evaluate the durability of that momentum. The post did not specify which Lockheed segments are leading the improvement, whether the confidence is tied to particular contract types, or what quantitative change underlies the target adjustments beyond the general reference to accelerating momentum.

What to watch next is whether Lockheed Martin’s own communications, such as contract updates or quarterly results, align with the “not priced in” view. Subsequent guidance on production rates, delivery schedules, and sustainment trends will be the clearest confirmation of whether analysts’ expectations are moving toward a faster earnings trajectory or whether they remain largely interpretive.

Why It Matters

  • Target increases and “not priced in” framing can announcement that sell-side expectations for defense contracting momentum are shifting upward.
  • If momentum improves across multiple segments, it can broaden the revenue and earnings support beyond a single program cycle.
  • Market focus may turn to whether Lockheed’s execution and delivery updates validate analysts’ higher-growth assumptions.

Sources

Key Facts

  • UBS said Lockheed Martin’s growth potential is not fully reflected in the stock price, according to a Yahoo Finance report.
  • The UBS view was described as building confidence in accelerating momentum across Lockheed’s segments.
  • Citi raised its Lockheed Martin price target to $706 from $691 while keeping a Buy rating, per the same report.
  • The Yahoo Finance write-up described upside potential as roughly 15% in LMT shares, attributed to the analyst commentary.

Defense Related